Total Payments
$1,494
2024 Payments
$357.42
Companies
31
Transactions
57
Medicare Patients
779
Medicare Billing
$44,952
Payment Breakdown by Category
Food & Beverage$1,494 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,494 | 57 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $186.42 | 7 | $0 (2024) |
| Kite Pharma, Inc. | $121.20 | 1 | $0 (2022) |
| Amgen Inc. | $115.37 | 5 | $0 (2023) |
| PFIZER INC. | $115.06 | 6 | $0 (2024) |
| Genentech, Inc. | $93.61 | 2 | $0 (2023) |
| Seagen Inc. | $83.15 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $78.79 | 3 | $0 (2024) |
| Celgene Corporation | $55.19 | 2 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $50.03 | 2 | $0 (2024) |
| Janssen Biotech, Inc. | $47.78 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $357.42 | 15 | Merck Sharp & Dohme LLC ($89.98) |
| 2023 | $977.25 | 39 | Amgen Inc. ($115.37) |
| 2022 | $159.05 | 3 | Kite Pharma, Inc. ($121.20) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/07/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/31/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: ONCOLOGY | ||||||
| 07/17/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Oncology | ||||||
| 07/11/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $32.00 | General |
| 06/12/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $34.27 | General |
| Category: ONCOLOGY | ||||||
| 05/29/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: Oncology | ||||||
| 05/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: ONCOLOGY | ||||||
| 05/13/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: HORMONE THERAPY | ||||||
| 05/02/2024 | PFIZER INC. | IBRANCE (Drug), ELREXFIO, TUKYSA | Food and Beverage | In-kind items and services | $31.05 | General |
| Category: ONCOLOGY | ||||||
| 05/01/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $34.50 | General |
| 03/20/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: ONCOLOGY | ||||||
| 03/19/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: ONCOLOGY | ||||||
| 03/12/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Oncology | ||||||
| 01/08/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $22.89 | General |
| Category: Oncology | ||||||
| 12/20/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2023 | Seagen Inc. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: Oncology | ||||||
| 11/03/2023 | EMD Serono, Inc. | BAVENCIO (Drug) | Food and Beverage | Cash or cash equivalent | $30.19 | General |
| Category: Oncology | ||||||
| 10/27/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.68 | General |
| 10/23/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/16/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2023 | Merck Sharp & Dohme LLC | LYNPARZA (Biological), WELIREG | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: ONCOLOGY | ||||||
| 10/06/2023 | Genentech, Inc. | — | Food and Beverage | In-kind items and services | $46.73 | General |
| 09/26/2023 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: HEMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 216 | 241 | $74,103 | $15,661 |
| 2022 | 6 | 186 | 248 | $69,275 | $9,465 |
| 2021 | 7 | 194 | 270 | $65,292 | $9,883 |
| 2020 | 6 | 183 | 228 | $52,416 | $9,944 |
Total Patients
779
Total Services
987
Medicare Billing
$44,952
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 145 | 163 | $42,822 | $8,992 | 21.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 63 | $23,428 | $5,041 | 21.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 15 | $7,852 | $1,628 | 20.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 75 | 114 | $36,367 | $4,866 | 13.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 45 | $18,189 | $2,176 | 12.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 37 | 37 | $12,206 | $1,733 | 14.2% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 12 | 12 | $750.84 | $426.24 | 56.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 14 | 25 | $1,465 | $230.72 | 15.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 11 | 15 | $297.00 | $33.37 | 11.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 72 | 121 | $35,512 | $5,023 | 14.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 38 | $14,193 | $1,867 | 13.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 28 | 28 | $8,691 | $1,409 | 16.2% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 15 | 15 | $2,906 | $991.02 | 34.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 16 | 31 | $2,511 | $301.01 | 12.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 16 | 16 | $828.00 | $244.64 | 29.5% |
| 81003 | Automated urinalysis test | Office | 2021 | 17 | 21 | $651.00 | $47.25 | 7.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 43 | 43 | $11,933 | $4,391 | 36.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 67 | 99 | $27,438 | $3,311 | 12.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 28 | $9,793 | $1,644 | 16.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 19 | 20 | $974.00 | $349.45 | 35.9% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 14 | 22 | $1,782 | $212.48 | 11.9% |
| 81003 | Automated urinalysis test | Office | 2020 | 15 | 16 | $496.00 | $36.00 | 7.3% |
About Melissa Walsh, P.A
Melissa Walsh, P.A is a Physician Assistant healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2014. The National Provider Identifier (NPI) number assigned to this provider is 1033512918.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Melissa Walsh, P.A has received a total of $1,494 in payments from pharmaceutical and medical device companies, with $357.42 received in 2024. These payments were reported across 57 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($1,494).
As a Medicare-enrolled provider, Walsh has provided services to 779 Medicare beneficiaries, totaling 987 services with total Medicare billing of $44,952. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Salem, OR
- Active Since 10/06/2014
- Last Updated 12/01/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1033512918
Products in Payments
- Yescarta (Drug) $121.20
- KEYTRUDA (Biological) $98.24
- LYNPARZA (Biological) $56.18
- TUKYSA (Drug) $37.80
- Orserdu (Drug) $35.02
- REBLOZYL (Biological) $35.00
- ELIQUIS (Drug) $33.77
- Kyprolis (Drug) $32.09
- IBRANCE (Drug) $31.05
- INLYTA (Drug) $30.94
- BAVENCIO (Drug) $30.19
- Enhertu (Drug) $29.99
- Nubeqa (Drug) $29.69
- Nplate (Biological) $29.09
- Epkinly (Drug) $28.88
- TIVDAK (Biological) $28.43
- ORGOVYX (Drug) $27.31
- MONOFERRIC (Drug) $27.10
- PROLARIS (Device) $25.92
- LUMAKRAS (Drug) $24.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Salem
Shawn Hill, Mpas, MPAS
Physician Assistant — Payments: $16,101
Physician Assistant $16,101
Mrs. Olivia Darwin, Pa-C, PA-C
Physician Assistant — Payments: $9,122
Physician Assistant $9,122
Shannon Snyder, Pa-C, PA-C
Physician Assistant — Payments: $8,469
Physician Assistant $8,469
Eric Harmon, Pa, PA
Physician Assistant — Payments: $8,455
Physician Assistant $8,455
Robert Wollenzien
Physician Assistant — Payments: $7,551
Physician Assistant $7,551
Jordan Young, Pa-C, PA-C
Physician Assistant — Payments: $7,356
Physician Assistant $7,356